We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+4.3%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$82B
AUM Growth
+$9.65B
(+13%)
Cap. Flow
+$7.43B
Cap. Flow
% of AUM
9.05%
Top 10 Holdings %
Top 10 Hldgs %
31.42%
Holding
1,609
New
45
Increased
827
Reduced
158
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$447M |
| 2 |
Apple
AAPL
|
+$383M |
| 3 |
Constellation Brands
STZ
|
+$378M |
| 4 |
NVIDIA
NVDA
|
+$371M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$331M |
| 2 |
Amphenol
APH
|
+$240M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$74.4M |
| 4 |
Veralto
VLTO
|
+$69.6M |
| 5 |
iShares MBS ETF
MBB
|
+$33.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.94% |
| 2 | Healthcare | 14.3% |
| 3 | Financials | 13.12% |
| 4 | Consumer Discretionary | 8.56% |
| 5 | Communication Services | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Stevanato
STVN
$5.75B
| $273K | ﹤0.01% |
14,905
+2,416
| +19% | +$56.2K |
|
927
Beam Therapeutics
BEAM
$2.77B
| $272K | ﹤0.01% |
11,610
+3,970
| +52% | +$97.5K |
|
|
ALX
928
Alexander's
ALX
$1.39B
| $271K | ﹤0.01% |
1,205
| – | – |
|
|
LAND
929
Gladstone Land Corp
LAND
$354M
| $266K | ﹤0.01% |
19,400
| – | – |
|
|
CLDT
930
Chatham Lodging
CLDT
$580M
| $265K | ﹤0.01% |
31,108
| – | – |
|
|
AUTL
931
Autolus Therapeutics
AUTL
$620M
| $259K | ﹤0.01% |
+74,398
| New | +$321K |
|
932
Fate Therapeutics
FATE
$319M
| $255K | ﹤0.01% |
+77,816
| New | +$341K |
|
|
VERV
933
DELISTED
Verve Therapeutics
VERV
| $254K | ﹤0.01% |
51,971
+32,958
| +173% | +$207K |
|
934
Intellia Therapeutics
NTLA
$1.68B
| $253K | ﹤0.01% |
11,287
+3,438
| +44% | +$81.9K |
|
935
BioNTech
BNTX
$23.3B
| $251K | ﹤0.01% |
3,127
+749
| +31% | +$68.5K |
|
936
Vir Biotechnology
VIR
$1.51B
| $251K | ﹤0.01% |
28,200
+4,221
| +18% | +$40.5K |
|
937
OmniAb
OABI
$491M
| $250K | ﹤0.01% |
66,648
+14,657
| +28% | +$66.8K |
|
938
Accuray
ARAY
$34.6M
| $247K | ﹤0.01% |
135,594
+82,004
| +153% | +$156K |
|
939
Novavax
NVAX
$1.31B
| $244K | ﹤0.01% |
19,311
-21,917
| -53% | -$220K |
|
940
Editas Medicine
EDIT
$453M
| $244K | ﹤0.01% |
52,254
+30,575
| +141% | +$172K |
|
941
Tango Therapeutics
TNGX
$4.44B
| $244K | ﹤0.01% |
+28,380
| New | +$219K |
|
942
Ocugen
OCGN
$465M
| $241K | ﹤0.01% |
+155,633
| New | +$242K |
|
943
4D Molecular Therapeutics
FDMT
$600M
| $240K | ﹤0.01% |
11,448
-7,519
| -40% | -$189K |
|
|
PKST
944
DELISTED
Peakstone Realty Trust
PKST
| $240K | ﹤0.01% |
22,620
| – | – |
|
945
Neurogene
NGNE
$714M
| $237K | ﹤0.01% |
+6,519
| New | +$230K |
|
946
Xencor
XNCR
$1.64B
| $236K | ﹤0.01% |
12,482
+298
| +2% | +$6.4K |
|
947
Arcturus Therapeutics
ARCT
$214M
| $235K | ﹤0.01% |
9,646
+7
| +0.1% | +$212 |
|
948
Immatics
IMTX
$1.33B
| $232K | ﹤0.01% |
+19,944
| New | +$225K |
|
949
Wave Life Sciences
WVE
$993M
| $227K | ﹤0.01% |
+45,557
| New | +$260K |
|
|
OLP
950
One Liberty Properties
OLP
$515M
| $226K | ﹤0.01% |
9,618
| – | – |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q2 2024 Portfolio in Review
As of Q2 2024, Mitsubishi UFJ Asset Management held 1,609 positions worth $82B, up 13% from $72.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Mitsubishi UFJ Asset Management deployed $7.43B of net new capital in Q2 2024, opening 45 new positions and adding to 827 existing holdings. Its largest new stake was GE Vernova: 369,082 shares worth $63.3M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $331M trimmed.
- Mitsubishi UFJ Asset Management's largest Q2 2024 buy was GE Vernova: 369,082 shares worth $63.3M.
- Mitsubishi UFJ Asset Management added most to Microsoft in Q2 2024, an estimated $447M increase.
- Mitsubishi UFJ Asset Management's biggest Q2 2024 reduction was Philip Morris, cutting an estimated $331M.
- Mitsubishi UFJ Asset Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $74.4M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 31% of its $82B portfolio in Q2 2024.
- Mitsubishi UFJ Asset Management opened 45 new positions and closed 37 in Q2 2024.
- Mitsubishi UFJ Asset Management's portfolio value rose 13% quarter-over-quarter to $82B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.